Company

Zhi Pet Pharmaceutical

Zhi Pet Pharmaceutical develops animal medicines using genomic screening and AI-assisted drug design.

About

Based in Beijing, China, Zhi Pet Pharmaceutical develops animal drugs using genomic screening and AI-assisted design. Its ZC001 product is an anti-coronavirus drug for animals, and its platforms support animal genome-wide CRISPR screening and AI-assisted design of large and small molecules. Founded in 2022, the company raised angel funding in July 2023, led by Legend Star with participation from MiraclePlus China.

1Funding rounds

2Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in